Schecter Alison D. 4
4 · Axcella Health Inc. · Filed Feb 10, 2022
Insider Transaction Report
Form 4
Schecter Alison D.
President - Research & Dev.
Transactions
- Award
Stock Option (Right to Buy)
2022-02-08+56,000→ 56,000 totalExercise: $1.63Exp: 2032-02-07→ Common Stock (56,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.